GIP & GLP-1 is an innovative peptide designed to aid in weight management and improve glycemic control
doi: 10.1111/jdv.17079 88
Additionally, this study was limited by a follow-up duration of only 12 months and was conducted at a single center, rather than multiple centers
Claim Your Risk-Free Consultation How Our Medical Weight Loss Program Works in Jupiter Heres the simple, proven process that helps many patients lose 1520 lbs in the first 30 days with our Medical Weight Loss Jupiter FL program: Step 1: Private Consultation We review your goals, health history, and labs to confirm eligibility
This extended protocol adds intermediate dose steps (0.5mg, 3mg, 6mg) that do not appear in the standard clinical trial schedule
A Phase 2 trial of CX11, an investigational once-daily oral GLP-1 receptor agonist, reported up to 11.5% mean weight loss at 36 weeks, with weight loss continuing through the end of the study